Core Viewpoint - Microelectrophysiology has seen a significant stock price increase, with a 5.16% rise on November 5, reaching 25.90 CNY per share, and a total market capitalization of 12.189 billion CNY [1] Group 1: Company Overview - Shanghai Microelectrophysiology Medical Technology Co., Ltd. was established on August 31, 2010, and went public on August 31, 2022 [1] - The company specializes in the research, development, production, and sales of innovative medical devices in the field of electrophysiological interventional diagnosis and ablation therapy [1] - Revenue composition includes catheter products at 71.77%, other products at 20.22%, equipment at 7.24%, and leasing services at 0.77% [1] Group 2: Fund Holdings - One fund under China Europe Fund has a significant holding in Microelectrophysiology, specifically the China Europe CSI 1000 Index Enhanced A (017919), which held 97,300 shares, accounting for 0.42% of the fund's net value [2] - The fund has realized a floating profit of approximately 123,600 CNY today and 291,000 CNY during the five-day price increase [2] - The fund was established on March 2, 2023, with a current size of 239 million CNY and has achieved a year-to-date return of 29.63% [2] Group 3: Fund Manager Performance - The fund manager Qian Yating has a tenure of 4 years and 4 days, with a total asset size of 5.022 billion CNY and a best return of 60.5% during her tenure [3] - Co-manager Song Ting has been in position for 258 days, managing assets of 2.731 billion CNY, with a best return of 30.43% [3]
微电生理股价涨5.16%,中欧基金旗下1只基金重仓,持有9.73万股浮盈赚取12.36万元